Harpeth Capital Advises PCA Southeast

Harpeth Capital, LLC is pleased to announce that it served as exclusive financial advisor to PCA of Columbia, Inc. d/b/a PCA Southeast in connection with the sale of its cytology division to Laboratory Corporation of America Holdings (NYSE:LH). The transaction closed on March 14, 2014. Founded in 1960 and headquartered in Columbia, TN, PCA is a leading provider of anatomic pathology services to clients across middle Tennessee and surrounding areas reaching five states.

“We enjoyed working with the team at Harpeth Capital to identify and structure a transaction that made sense for PCA and its shareholders,” said Dr. Terry Pearson, Partner, President and Chief Manager. “Our industry has seen significant changes in the last couple years that, combined with the goals of our shareholders, served as catalysts for us seeking strategic alternatives for our business. We are excited about our relationship with LabCorp going forward.”

“We enjoyed getting to know the doctors at PCA both personally and professionally,” said Adam Landa, Managing Director. “We were honored they put their trust in Harpeth Capital to guide them through this process and transaction.”